為達最佳瀏覽效果,建議使用 Chrome、Firefox 或 Microsoft Edge 的瀏覽器。

請至Edge官網下載 請至FireFox官網下載 請至Google官網下載
晴時多雲

限制級
您即將進入之新聞內容 需滿18歲 方可瀏覽。
根據「電腦網路內容分級處理辦法」修正條文第六條第三款規定,已於網站首頁或各該限制級網頁,依台灣網站分級推廣基金會規定作標示。 台灣網站分級推廣基金會(TICRF)網站:http://www.ticrf.org.tw

《TAIPEI TIMES》 CDC signs Monkeypox drug deal

Kyle Planck, who has recovered from monkeypox, holds a bottle of Tecovirimat, which is used to treat the virus, in New York on Tuesday last week.
Photo: AFP

Kyle Planck, who has recovered from monkeypox, holds a bottle of Tecovirimat, which is used to treat the virus, in New York on Tuesday last week. Photo: AFP

2022/07/25 03:00

ALWAYS BE PREPARED: The CDC said vaccines would hopefully arrive before the end of next month, while the antiviral would only be made available for severe cases

By Lee I-chia / Staff reporter

A contract has been signed to purchase an antiviral used to treat monkeypox, with the drug expected to arrive next month at the earliest, the Centers for Disease Control (CDC) said yesterday, adding that negotiations for monkeypox vaccines are ongoing.

The WHO on Saturday declared a global monkeypox outbreak a public health emergency of international concern.

The centers said it would monitor the spread of the disease, while urging doctors to report suspected cases within 24 hours, as it has been listed as a category 2 notifiable infectious disease.

Ten suspected cases have been reported in Taiwan so far, while one Taiwanese who returned from Germany and one who returned from the US were confirmed to have monkeypox, the centers said.

People who experience suspected monkeypox symptoms should seek medical treatment immediately and report their travel history to a doctor, it added.

CDC Deputy Director-General Chuang Jen-hsiang (莊人祥) said that the centers signed a contract to purchase Tecovirimat, an antiviral used to treat monkeypox, and a flight for its delivery is being arranged.

The amount of Tecovirimat purchased would be kept confidential for now, he said, adding that the drug would be administered to severe cases and people with a high risk of developing severe illness.

The centers is negotiating a procurement contract for the Modified Vaccinia Ankara-Bavarian Nordic vaccine, a third-generation smallpox vaccine that could be useful for preventing monkeypox, Chuang said, adding that it would hopefully arrive before the end of next month.

The centers said that as global monkeypox cases began escalating and were reported in neighboring countries last month, it listed monkeypox as a category 2 notifiable infectious disease on June 23, and invited experts to plan the procurement of antiviral drugs and vaccines, as well as establish a standard procedure for testing.

The centers on June 30 also issued a level 2 alert travel warning for 49 countries where local monkeypox cases or cases with unknown infection source had been reported.

A total of 16,836 cases have been confirmed in 74 countries or areas, from when the outbreak began in May to Friday, it said, adding that the outbreak is currently more prevalent in European countries and the US.

新聞來源:TAIPEI TIMES

不用抽 不用搶 現在用APP看新聞 保證天天中獎  點我下載APP  按我看活動辦法

焦點今日熱門
看更多!請加入自由時報粉絲團

網友回應

載入中
此網頁已閒置超過5分鐘,請點擊透明黑底或右下角 X 鈕。